IR is characterized by glucose dysregulation with elevated serum insulin level, which increases the risk for metabolic syndromes such as T2DM, CVD and polycystic ovary syndrome (PCOS) (122–125). This evidence concerns the gene INS and type 2 diabetes mellitus.